Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS
在老年急性髓系白血病(AML)和高危骨髓增生异常综合征(MDS)患者的标准强化治疗中加入氨肽酶抑制剂托塞多司他,疗效较差。
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers13040672
Janssen, Jeroen; Löwenberg, Bob; Manz, Markus; Bargetzi, Mario; Biemond, Bart; von dem Borne, Peter; Breems, Dimitri; Brouwer, Rolf; Chalandon, Yves; Deeren, Dries; Efthymiou, Anna; Gjertsen, Bjørn-Tore; Graux, Carlos; Gregor, Michael; Heim, Dominik; Hess, Urs; Hoogendoorn, Mels; Jaspers, Aurelie; Jie, Asiong; Jongen-Lavrencic, Mojca; Klein, Saskia; Klift, Marjolein van der; Kuball, Jürgen; Lammeren-Venema, Danielle van; Legdeur, Marie-Cecile; Loosdrecht, Arjan van de; Maertens, Johan; Kooy, Marinus van Marwijk; Moors, Ine; Nijziel, Marten; Obbergh, Florence van; Oosterveld, Margriet; Pabst, Thomas; Poel, Marjolein van der; Sinnige, Harm; Spertini, Olivier; Terpstra, Wim; Tick, Lidwine; Velden, Walter van der; Vekemans, Marie-Christiane; Vellenga, Edo; Weerdt, Okke de; Westerweel, Peter; Stüssi, Georg; Norden, Yvette van; Ossenkoppele, Gert